Inventor
Gopalan Raghunathan
Inventor
San Diego, CA, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
A61KPreparations for medical, dental or toiletry purposes20%
C12NMicroorganisms or enzymes8%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
C07HSugars5%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture5%
Y02ATechnologies for adaptation to climate change4%
C40BCombinatorial chemistry1%
PatentTitleYear
10,941,197Method of treating osteoarthritis with human oncostatin M antibodies202110,898,571Anti-LAG3 antibodies and antigen-binding fragments202110,894,829Humanized antibody for treating or preventing cognitive disorders, process for producing the same, and agent for treating or preventing cognitive disorders using the same202110,618,958Anti-TIGIT antibodies202010,556,950Humanized antibody for treating or preventing cognitive disorders, process for producing the same, and agent for treating or preventing cognitive disorders using the same202010,188,730Anti-LAG3 antibodies and antigen-binding fragments201910,179,812Method of treating idiopathic pulmonary fibrosis by administering human oncostatin M antibodies20199,587,018'Polynucleotides encoding human oncostatin M antibodies'20179,163,083'Human oncostatin M antibodies'20159,156,917'CH2 domain template molecules derived from rational grafting of donor loops onto CH2 scaffolds'20158,999,333'Human tissue factor antibody and uses thereof'20158,951,525'Human tissue factor antibody and uses thereof'20158,748,356'Methods for use in human-adapting monoclonal antibodies'20148,722,044'Human tissue factor antibody and uses thereof'20148,580,714'Methods of affinity maturing antibodies'20138,399,630'Engineered anti-IL-13 antibodies, compositions, methods and uses'20138,323,646'Engineered anti-IL-13 antibodies, compositions, methods and uses'20128,153,583'Toll like receptor 3 antagonists, methods and uses'20127,790,871'Anti-TNFα antibodies and methods of use'20107,560,108'Anti-TNFα antibodies'2009Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2009–2015Patents assigned to RAGHUNATHAN GOPALAN (9)· patent assignee history
2009–2021Based in San Diego, CA, US· patent location history
2012–2013Patents assigned to CARTON JILL M (3)· patent assignee history
2012–2014Patents assigned to CHI ELLEN (3)· patent assignee history
2013–2021Patents assigned to JANSSEN BIOTECH INC (9)· patent assignee history
2019–2021Patents assigned to MERCK SHARP & DOHME (5)· patent assignee history
2020–2021Based in Santa Clara, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JANSSEN BIOTECH INC | 9 | 2013–2021 |
| RAGHUNATHAN GOPALANself | 9 | 2009–2015 |
| MERCK SHARP & DOHME | 5 | 2019–2021 |
| CARTON JILL M | 3 | 2012–2013 |
| CHI ELLEN | 3 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 18 | 2009–2021 |
| Santa Clara, California, US | 2 | 2020–2021 |